Archives

by in
Entry Author Date Location
See Clay Siegall, Kim Popovits, Mitch Gold This Afternoon 04/09/13 Seattle
Biotech for the Belt-Tightening Era: Last Chance For Early-Bird Tix 03/12/13 Seattle
Alder Biopharma Looks to Take On Migraines, and the World 01/24/13 Seattle
Alder Gets $3.5M Milestone as Bristol-Myers Starts Crohn’s Study 08/27/12 Seattle
Alder Biopharma Snags $38M To Charge Ahead With Antibody Drugs 04/19/12 Seattle
Alder Biopharmaceuticals Receives $38,000,000 Series D Financing Round 04/19/12 Seattle
Biotech Can’t Sidestep Cost-Effectiveness Anymore 04/02/12 National
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
Thong Le Named New Chairman of WBBA, Replacing Tom Clement 10/07/11 Seattle
Theraclone Nabs Industry Award, Scopes Out Extra $10M Financing 09/06/11 Seattle
Allozyne’s Backdoor IPO, Sound Pharma Fights iPod Deafness, Mirina Vs. Marina Ends, & More Seattle-Area Life Sciences News 06/23/11 Seattle
Alder Gets $15M From Bristol 06/20/11 Seattle
Immune Design Gets New CEO, Seattle Biomed Nabs $9M, VCs Turn Up Heat on FDA, & More Seattle-Area Life Sciences News 04/28/11 Seattle
Dendreon Moves Across Town, SeaGen Files FDA App, Alder Takes Road Less Traveled, & More Seattle Life Sciences News 03/03/11 Seattle
Editor’s Picks: The Best of 2010 From Xconomy Seattle 12/23/10 Seattle
Biotech’s Back in Seattle: Photo Gallery 11/30/10 Seattle
See You Tonight at “Biotech’s Back in Seattle” 11/29/10 Seattle
Who Will Keep the Flame Alive for Seattle Biotech? Hear From the Players Nov. 29 11/09/10 Seattle
Dendreon’s Plan to Meet Demand, Arch Banks on Ikaria IPO, RF Surgical Leaves No Sponge Behind, & More Seattle-Area Life Sciences News 11/04/10 Seattle
Montgomery Joins Alder Board 11/01/10 Seattle
Seattle Genetics Nails 2nd Trial, Bristol Clinches Zymo Buyout, Halosource Goes Public, & More Seattle-Area Life Sciences News 10/14/10 Seattle
Biotech’s Back in Seattle: Xconomy Forum to Convene Leaders of Dendreon, Seattle Genetics 10/13/10 Seattle
Seattle Genetics’ Dark Horse Fails, The Future of Zymo’s Landmark, PATH Nabs Flu Vaccine Contract, & More Seattle-Area Life Sciences 09/16/10 Seattle
Fierce 15 Shines Light on Some of Our Favorite Companies in Boston and Beyond 09/15/10 National
Alder Wins Fierce 15 Honor 09/15/10 Seattle
KaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader 08/17/10 San Francisco
Femta Pharmaceuticals Snags $2.2M for Potent Antibody Drugs 07/13/10 San Diego
Xconomy Seattle’s Top 20 Stories of the Quarter: The Quest for the Land Speed Record, Dendreon Makes History, & Geoff Entress Up Close 07/02/10 Seattle
SF and Silicon Valley: Drop the Incrementalism and Invest in True Innovation 06/21/10 San Francisco
ZymoGenetics Gets Upstaged, Calistoga Cancer Drug Matures, Cramer Replaces Kraemer, & More Seattle-Area Life Sciences News 06/11/10 Seattle
Page 1 of 2 next page »